Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE

Showing 15 posts of 866 posts found.

CDF image

Cancer Drugs Fund: assessing a difficult legacy

February 3, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, NHS, NICE, adams, mccafferty

England’s Cancer Drugs Fund (CDF) is very good at creating division: its lobbyists say that it increases access to new …

Feature

NICE looks at Xtandi again

January 28, 2014
Sales and Marketing Astellas, NHS, NICE, Xtandi

NICE has announced it is to consult again on its decision to recommend Astellas Pharma’s prostate cancer drug Xtandi after …

News
doh image

NICE rejects ‘benefit’ test

January 28, 2014
Sales and Marketing Dillon, EMIG, NHS, NICE, benefits

NICE has refused to include a ‘wider societal benefit’ test into its deliberations about which drugs should be available on …

News

Mail backs down over NICE ‘champagne perks’ attack

January 24, 2014
Medical Communications, Sales and Marketing Daily Mail, NHS, NICE, UK, spending

The Daily Mail newspaper has backed down on an article it published earlier this month, which alleged that staff at …

News
abpi image

ABPI: NHS must explain drugs take-up

January 22, 2014
Sales and Marketing ABPI, NHS, NICE, Whitehead

The ABPI has called on the NHS to explain what it says is the ‘substantial variation’ in NHS patients’ access …

News
Aubagio image

NICE recommends Aubagio

January 22, 2014
Sales and Marketing Aubagio, EU, FDA, NICE, Sanofi, gilenya

NICE has recommended Genzyme’s multiple sclerosis pill Aubagio for use on the NHS. In final guidance the watchdog said Aubagio …

News
NICE image

NICE: Daily Mail ‘misled’ readers

January 13, 2014
Sales and Marketing Dillon, NHS, NICE, mail

UK drugs watchdog NICE has hit back at an article in the Daily Mail headlined “Champagne perks of NHS drug …

News
NICE image

NICE must get tougher on pharma, urges BMJ journal

December 16, 2013
Sales and Marketing BMJ, NHS, NICE, pharma

The UK should have one universal health technology assessor which should seek to tighten up rules on whether new drugs …

News
NICE image

NICE wants more Lemtrada data

December 6, 2013
Sales and Marketing Lemtrada, MS, NICE, Sanofi

NICE has said there are ‘still questions to be answered’ over Sanofi’s submission of its multiple sclerosis drug Lemtrada and …

News
Pfizer image

NICE rejects Bosulif

November 28, 2013
Sales and Marketing CML, NHS, NICE, Pfizer, bosulif

 In a blow for Pfizer NICE has categorically rejected the manufacturer’s Bosulif as a treatment for previously-treated chronic myeloid leukaemia …

News
Lucentis image

NICE gives Lucentis more scope

November 27, 2013
Sales and Marketing Lucentis, NICE, Novartis, cnv

An undisclosed price cut from Novartis has been enough to swing NICE towards using the manufacturer’s Lucentis in a fourth …

News
NHS image

PPRS deal ‘dreadful’, says EMIG

November 26, 2013
Sales and Marketing EMIG, NHS, NICE, PPRS, VBP

The Ethical Medicines Industry Group (EMIG) has slammed the new PPRS plan, calling it a ‘dreadful deal’ for its members. …

News
EMA image

EMA looks to sharpen HTA data output

November 20, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, NICE, hta, transparency

The European Medicines Agency (EMA) has deepened its partnership with the European network for Health Technology Assessment (EUnetHTA) as it …

News
NICE image

NICE tells pharma: don’t blame us for rejections

November 18, 2013
Sales and Marketing Dillon, NHS, NICE, VBP

The head of NICE has publicly defended his agency against more pharma criticism but admits that it can make changes …

News
Velcade image

NICE needs more Velcade data

November 12, 2013
Sales and Marketing NHS, NICE, Velcade, eric low

NICE has slowed the progress of Janssen Cilag’s Velcade towards becoming an NHS treatment for multiple myeloma by asking the …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026